The category continues attracting new entrants while facing evolving regulatory scrutiny, creating a dynamic market environment where platform differentiation increasingly centers on pricing structure, medication formulation options, and operational transparency regarding the separation between technology services and medical decision-making
GLP-1 patches would be developed primarily for type 2 diabetes mellitus and obesity management, working through improved glycaemic control, reduced appetite, increased satiety, and delayed gastric emptying, similar to current injectable GLP-1 medications
A quarter to a third of those affected are dependent on nursing support (Ward et al., 2005
In 2024, 66% of the global revenue was listed in the hospitals & clinics segment
Theres no rash or anything to see